Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Strong annual results from Springfield, Fiske

Tue, 14th Sep 2021 17:46

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Springfield Properties PLC - Scottish housebuilder - For the year ended May 31, pretax profit rises 81% to GBP18.5 million from GBP10.2 million, on revenue growing 51% year-on-year to GBP216.7 million from GBP143.5 million, driven by higher sales and demand in private and affordable housing. Total completes increases to 973 homes from 727, as the average selling price for private housing rises to GBP244,000 from GBP236,000. Declares dividend of 5.75 pence, more than doubled from 2.0p the prior year.

----------

Harworth Group PLC - Rotherham, Yorkshire-based land regenerator - For the six months ended June 30, swings to pretax profit of GBP80.1 million from loss of GBP3.7 million, due to revaluation gains on properties and assets of GBP105.7 million. In addition, revenue declined 20% year-on-year to GBP18.9 million from GBP23.7 million due to later starts on site in 2020 due to the pandemic. As at June 30, net asset value per share was 167.8p, up from 142.2p the same date the year prior, while the portfolio value stands at GBP748.0 million from GBP618.2 million at the end of December. Declares interim dividend of 0.36 pence per share, up from 0.33p a year prior.

----------

Aberdeen Smaller Companies Income Trust PLC - invests in UK small-cap stocks - Net asset value total return for the six months ended June 30 was 20.1%, compared to the Numis Smaller Companies excluding Investment Trust index, which returned 17.4%. As at June 30, NAV per share is 413.97 pence, up 19% from 348.91p at the end of December.

----------

Henderson High Income Trust PLC - pure income trust investing in dividend-paying UK companies - For the first half of 2021, net asset value total return was 12.3%, while its benchmark - a composite made up 80% of the FTSE All-Share index and 20% of the ICE BofAML Sterling Non-Gilts index - returned 8.4%. At the end of June, NAV per share was 171.6 pence, up % from 157.3p at December 31.

----------

Phoenix Global Resources PLC - upstream oil and gas company - For the first half of 2021, pretax loss narrows to USD3.9 million from USD62.1 million the same period a year before, on revenue which grows 45% year-on-year to USD36.1 million from USD24.9 million. Revenue growth was due to higher oil sales during the period, mainly through the shut-in of production due to Covid-19 in 2020 and the rise in oil prices to USD47.03 per barrel to USD39.19.

----------

Infrastructure India PLC - investor in infrastructure assets in India's energy and transport sectors - Renewable assets are currently operating in line with expectations due to steady demand for power. As at August 31, cash position stands at USD3.5 million, and the company continues to evaluate options and find alternative sources of financing. As at March 31, expects to report net asset value per share between 10p to 13p. Applies to AIM for three-month extension for its annual results, which is expected to be published in October.

----------

ThinkSmart Ltd - Australian digital payments platform - For the year ended June 30, pretax profit rises 35% to GBP71.7 million from GBP53.1 million the year before, mainly due to a higher gain on financial instruments on the revaluation of the group's investment in ClearPay Finance Ltd due to a strong performance from the investee. However, revenue dropped 31% year-on-year to GBP4.3 million from GBP6.3 million on a drop in leasing volumes.

----------

Porvair PLC - Norfolk, England-based filtration and environmental technology firm - Trading for the third quarter ended August 31 is ahead of expectations, with healthy order books in industrial processes, laboratory and aluminium. However, due to supply chain issues, company has deemed it too early to determine its annual performance.

----------

Good Energy Group PLC - Chippenham, England-based energy company - For the first half of 2021, swings to pretax profit of GBP4.8 million from loss of GBP1.1 million the same period a year before, on revenue which rises 1.4% year-on-year to GBP68.4 million from GBP67.5 million on an increase in customer numbers. Intends to recommend a dividend payment for 2021, and will pay 0.75p per share should the hostile offer by Ecotricity Group Ltd lapse or be withdrawn.

----------

Ovoca Bio PLC - Women's health-focused biopharmaceutical company - For the six months ended June 30, pretax loss widens to USD3.7 million from USD2.2 million a year before, due to a rise in administrative expenses and the generation of no revenue during the period.

----------

Kistos PLC - London-based energy sector investor - For the 37 weeks ended June 30, reports pretax loss of EUR5.2 million, on revenue of EUR6.6 million. On a proforma basis following the acquisition of Tulip Oil Netherlands BV, revenue rose 97% year-on-year to EUR33.7 million from EUR17.1 million. despite production falling 28% to 1,598 megawatt hours from 2,230MWh.

----------

MaxCyte Inc - Maryland, US-based biotechnology company - For the first half of 2021, net loss widens to USD11.5 million from USD6.1 million the year before, due to higher operating expenses through an increased headcount and higher stock-based compensation, as well as a rise in legal expenses. Meanwhile, revenue grows 25% to USD13.6 million from USD10.9 million, through higher sales in cell therapy and drug discovery markets.

----------

Property Franchise Group PLC - UK-based lettings and estate agency franchising firm - For the six months ended June 30, pretax profit rises 57% to GBP3.1 million from GBP2.0 million the same period a year prior, as well as a 54% increase from the first half of 2019. This is on revenue which more than doubles to GBP11.1 million from GBP5.1 million, on higher managed services fees and increased sales activity. Raises interim dividend by 81% to 3.8 pence from 2.1p. Looking ahead, expects 2021 annual profit performance to be ahead of market expectations.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - For the year ended June 30, pretax loss widens to GBP11.5 million from GBP5.3 million the year before due to higher expenses as the company sets up key studies designed to increased the value of Diurnal's pipeline. Revenue declines % year-on-year to GBP4.4 million from GBP6.3 million, driven by a drop in product sales and licensing income.

----------

Made.com Group PLC - London-based furniture retailer - For the six months ended June 30, pretax loss narrows to GBP10.1 million from GBP15.2 million, as revenue grows 61% year-on-year to GBP171.0 million from GBP106.3 million, driven by a 54% increase in gross sales to GBP213.9 million supported by high levels of market demand. Looking ahead, revenue for 2021 is expects to be around GBP410 million, reflecting a 65% increase.

----------

Fiske PLC - London-based stockbroker and investment manager - For the year ended May 31, pretax profit is GBP610,000, swinging from a loss of GBP127,000 the year before, on revenue which grows 13% year-on-year to GBP6.1 million from GBP5.4 million.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
10 Jan 2019 11:33

Diurnal Shares Surge As Secures Second Patent For Chronocort In US

LONDON (Alliance News) - Diurnal Group PLC on Thursday said the US Patent & Trademark Office has granted the company a second US patent for Chronocort.Diurnal shares almost tripled on a

Read more
10 Jan 2019 11:26

Diurnal awarded US patent for Chronocort product

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Thursday that the US Patent and Trademark Office (USPTO) has granted a second US patent for its 'Chronocort' modified release hydrocortisone product.

Read more
17 Oct 2018 12:10

Diurnal halts US development of Chronocort after European trials come up short

(Sharecast News) - Speciality pharmaceutical company Diurnal has put all development activities for its modified release hydrocortisone product on hold after it failed to meet its primary endpoint in a recent phase-three European trial.

Read more
17 Oct 2018 10:41

Diurnal Puts All Chronocort US Development Activities On Hold

LONDON (Alliance News) - Diurnal Group PLC said Wednesday it decided to put all US development activities for its Chronocort product on hold, after it failed to meet its primary objective in its a

Read more
8 Oct 2018 17:07

LONDON MARKET CLOSE: Stocks End Lower On Chinese And Italian Woes

LONDON (Alliance News) - Stocks closed lower Monday on the actions of the Chinese and Italian governments, as the pound continued its fall on news from 10 Downing Street there remains "big in of

Read more
8 Oct 2018 15:15

Diurnal Group Child Adrenal Insufficiency Drug Approved In Scotland

LONDON (Alliance News) - Diurnal Group PLC said Monday the Scottish Medicines Consortium approved the routine use of Alkindi, a first-line treatment of young children with adrenal insufficiency to

Read more
8 Oct 2018 12:00

LONDON MARKET MIDDAY: China Prompts Sell-Off In Europe; Insurers Fall

LONDON (Alliance News) - Share prices in London had slipped firmly into the red by midday on Monday following a slump in Chinese equities overnight."Europe is following the Asian lead, with a 3%

Read more
8 Oct 2018 10:33

WINNERS & LOSERS SUMMARY: French Connection In Vogue On Possible Sale

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - up 1.0%. The asset manager confirmed it is in to

Read more
8 Oct 2018 09:29

Diurnal's endocrine drug does not meet trial objective

(Sharecast News) - Clinical trials of Diurnal Group's Chronocort drug failed to meet the primary objective of proving superior to conventional therapy in endocrine control over a 24-hour period.

Read more
8 Oct 2018 08:54

Shares In IP Group, Diurnal Suffer After Chronocort Trial Disappoints

LONDON (Alliance News) - Diurnal Group PLC said Monday its phase-three European trial of Chronocort did not meet its primary objective, causing shares in the pharmaceutical company to property IP

Read more
8 Oct 2018 07:48

LONDON MARKET PRE-OPEN: Lower Call; Schroders Confirms Lloyds Talks

LONDON (Alliance News) - Stocks in London on Monday are set to continue last week's slide, fuelled by concerns that strong US economic data will lead to a quickened pace of interest rate hikes.In

Read more
5 Oct 2018 09:20

Diurnal kicks off adrenal condition trial with first patients

(Sharecast News) - Specialist pharmaceutical company Diurnal said it had enrolled the first two patients in its US-based Chronocort phase III trial for adults with congenital adrenal hyperplasia (CAH).

Read more
5 Oct 2018 08:16

Diurnal Enrols First Patients In Phase Three US Chronocort Trial

LONDON (Alliance News) - Pharmaceutical company Diurnal Group PLC on Friday said the first two patients have been enrolled into its phase three US trial of Chronocort.Chronocort is a form a

Read more
20 Sep 2018 09:56

Diurnal Generates First Revenue But Loss Deepens As Costs Rise

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC said Thursday its annual loss deepened amid higher costs despite generating its first revenue from drug sales.For the year the

Read more
15 Aug 2018 12:39

German Body Says Diurnal Alkindi's Benefit Over Generic Not Proven

LONDON (Alliance News) - Diurnal Group PLC said Wednesday a German body published a study which says that the benefit of the company's product Alkindi over generic hydrocortisone has not been

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.